PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cellular Genetics Laboratory, Graduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.\', \'Department of Chemistry, Biochemistry Division, Faculty of Science, Tanta University, Tanta, Egypt.\', \'Department of Organ and Cell Physiology, Juntendo University, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/ddr.21743
?:doi
?:hasPublicationType
?:journal
  • Drug development research
is ?:pmid of
?:pmid
?:pmid
  • 32984987
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.65
?:rankingScore_hIndex
  • 53
?:title
  • Superiority of cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32984987>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32984987>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all